Is avascular necrosis of the femoral head the result of inhibition of angiogenesis?

Medical Hypotheses

Volumn 49, Issue 6, 1997, Pages 497-500

  Smith, D W E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INTERFERON;

ANGIOGENESIS; AVASCULAR NECROSIS; BLOOD VESSEL OCCLUSION; FEMUR HEAD; HUMAN; HYPOTHESIS; PATHOGENESIS; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; RISK FACTOR; VASCULARIZATION;

EID: 0031471359     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(97)90067-0     Document Type: Article

References (33)

1. Chang C C, Greenspan A, Gershwin M E. Osteonecrosis: Current perspectives on pathogenesis and treatment. Seminars Arth Rheum 1993; 23: 47-69.
2. Ohzono K, Saito Z M, Takaoka K et al. Natural history of nontraumatic avascular necrosis of the femoral head. J Bone Joint Surg 1991; 73B: 68-72.
3. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333: 1757-1763.
4. Fishman S J, Mulliken J B. Hemangiomas and vascular malformations of infancy and childhood. Pediat Clin N Am 1993; 40: 1177-1200.
5. Lauta V M. Update on the use of interferons in clinical practice. Clinica Therapeutica 1995; 146: 393-448.
6. Lublin F D, Whitaker J N, Eidelmam B H et al. Management of patients receiving interferon-beta-1b for multiple sclerosis: report of a consensus conference. Neurology 1996; 46: 12-18.
7. Urabe A. Interferons for the treatment of hematological malignancies. Oncology 1994; 51: 137-141.
8. Sissons H A, Nuovo M A, Steiner G C. Pathology of osteonecrosis of the femoral head. Skel Radiol 1992; 21: 229-238.
9. Arlet J, Ficat R P, Hungerford D S (eds). Bone Circulation. Baltimore: Williams and Wilkins, 1984.
10. Massardo L, Jacobelli S, Leissner M et al. High-dose intravenous methylprednisolone therapy associated with osteonecrosis in patients with systemic lupus erythematosis. Lupus 1992; 1: 401-405.
11. Migliaresi S, Picillo U, Ambrosone L et al. Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus 1994; 3: 37-41.
12. Kwong F K, Sue M A, Klaustermeyer W B. Corticosteroid complications in respiratory disease. Ann Allergy 1987; 58: 326-330.
13. Uittenbogaart C H, Isaacson A S, Stanley P et al. Aseptic necrosis after renal transplantation in children. Am J Dis Child 1978; 132: 765-767.
14. Haajanen J, Saarinen O, Laasonen L et al. Steroid treatment and aseptic necrosis of the femoral head in renal transplant patients. Transplantation Proc 1984; 16: 1316-1319.
15. Susan L P, Braun W E, Banowsky L H, Straffon R A, Bergfeld J A. Avascular necrosis following renal transplantation: experience with 449 allografts with and without high dose steroid therapy. Urology 1978; 11: 225-229.
16. Wiernik P H, Dutcher J P, Paietta E et al. Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen. Leukemia 1993; 7: 1236-1241.
17. Balduzzi A, Gooley T, Anasetti C et al. Unrelated donor marrow transplantation in children. Blood 1995; 86: 3247-3256.
18. Hanif I, Mahmoud H, Pui C H. Avascular femoral head necrosis in pediatric cancer patients. Med Pediat Oncol 1993; 21: 655-660.
19. McNatt L G, Lane D, Clark A F. Angiostatic activity and metabolism of cortisol in the chorioallantoic membrane (CAM) of the chick embryo. J Steroid Biochem Mol Biol 1992; 42: 687-693.
20. Wolf J E, Guerin C, Laterra J et al. Dexamethazone reduces vascular density and plasminogen activator activity in 9L rat brain tumors. Brain Res 1993; 79-85.
21. Tobe T, Takahashi K, Ohkuma H, Uyama M. The effect of interferon-beta on experimental choroidal neovascularization. Acta Ophthalmol Jap 1995; 99: 571-581.
22. Pepper M S, Vassalli J D, Wilks J W, Schweigerer L, Montesano R. Regulation of bovine microvascular cell proteolytic properties by inhibitors of angiogenesis. J Cell Biochem 1994; 55: 419-434.
23. Blei F, Wilson E L, Mignatti P, Rifkin D B. Mechanism of action of angiogenic steroids: suppression of plasminogen activator via stimulation of plasminogen activator inhibitor synthesis. J Cell Physiol 1993; 155: 568-578.
24. Cockerill G W, Gamble J R, Vadas M A. Angiogenesis: models and modulators, Int Rev Cytol 1995; 159: 113-160.
25. Van Veldhuizen P J, Neff J, Murphey M D, Bodensteiner D, Skikne B S. Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Am J Hematol 1993; 44: 243-248.
26. Glueck C J. Friedberg R, Glueck H I et al. Hypofibrinolysis: a common cause of osteonecrosis. Am J Hematol 1994; 45: 156-166.
27. Sheramata W A, Taylor J R, Elgart G W. Severe necrotizing cutaneous lesions complicating treatment with interferon beta-1b. N Engl J Med 1995; 332: 1584.
28. Berard F, Canillot S, Balme B, Perrot H. Necrose cutanée localisé après injections d'interferon beta. Ann Derm Venereologie 1995; 122: 105-107.
29. Levesque H, Cailleux N, Moore N et al. Autoimmune phenomena associated with cutaneous aseptic necrosis during interferon-alpha treatment for chronic myelogenous leukemia. Br J Rheumatol 1995; 34: 582-583.
30. Brem H, Folkman J. Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med 1975; 141: 427-439.
31. Moses M A, Sudhalter J, Langer R. Identification of an inhibitor of neovascularization from cartilage. Science 1990; 248: 1408-1410.
32. Atsumi T, Kuroki Y. Role of impairment of blood supply of the femoral head in the pathogenesis of idiopathic osteonecrosis. Clin Orthoped Related Res 1992; 227: 22-30.
33. Tachjian M O. Pediatric Orthopedics. Philadelphia: Saunders, 1990.